Molecular topology as a novel approach for drug discovery

Expert Opinion on Drug Discovery

Volumn 7, Issue 2, 2012, Pages 133-153

  Gálvez, Jorge ^a   Glávez Llompart, María ^a   García Domenech, Ramón ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Drug discovery; Linear discriminant analysis; Molecular topology; Multilinear regression analysis; QSAR analysis

Indexed keywords

1,3 BIS(BENZYLOXYCARBONYL) 2 METHYL 2 THIOPSEUDOUREA; 2 CHLORO 2',6' ACETOXYLIDIDE; 4,6 DICHLORO 2 METHYL THIO 5 PHENYLPYRIMIDINE; A 2641934; A 3414817; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; BLINATUMOMAB; INDOMETACIN; MONENSIN; MT 477; NONSTEROID ANTIINFLAMMATORY AGENT; TRANS 1,3 DIPHENYL 2 PROPEN 1 OL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CARCINOGENICITY; DATA BASE; DRUG DESIGN; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; EXTERNAL VALIDITY; HUMAN; IC 50; LINEAR DISCRIMINANT ANALYSIS; MOLECULAR TOPOLOGY; MULTILINEAR REGRESSION ANALYSIS; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84856395918     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2012.652083     Document Type: Review

References (103)

1. Kwong E, Higgins J, Templeton AC. Strategies for bringing drug delivery tools into discovery. Int J Pharm 2011;412(1-2):1-7
2. Wermuth CG, Ganellin CR, Lindberg P, et al. Glossary of terms used in medicinal chemistry (IUPAC recommendations 1997). Annu Rep Med Chem 1998;33:385-95
3. Shankar R, Frapaise X, Brown B. LEAN drug development in R&D. Drug Discov Devel 2006;9(5):57-62
4. Kapetanovic I. Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chem Biol Interact 2008;171(2):165-76 (Pubitemid 351146652)
5. Hann M, Green R. Chemoinformatics-a new name for an old problem? Curr Opin Chem Biol 1999;3(4):379-83 (Pubitemid 29376098)
6. van de Waterbeemd H, Carter RE, Grassy G, et al. Glossary of terms used in computational drug design (IUPAC recommendations 1997). Annu Rep Med Chem 1998;33:397-409
7. CAS REGISTRY [Internet]. Available from: http://www.cas.org/index.html
8. Geppert H, Vogt M, Bajorath J. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation. J Chem Inf Model 2010;50(2):205-16
9. Simon-Hettich B, Rothfuss A, Steger-Hartmann T. Use of computer-assisted prediction of toxic effects of chemical substances. Toxicology 2006;224(1-2):156-62
10. Brown AC, Fraser T. On the connection between chemical constitution and physiological action. part I.-on the physiological action of the salts of the ammonium bases, derived from strychnia, brucia, thebaia, codeia, morphia, and nicotia. J Anat Physiol 1868;2(2): 224-42
11. Grover M, Singh B, Bakshi M, Singh S. Quantitative structure-property relationships in pharmaceutical research-part 1. Pharm Sci Technol Today 2000;3(1):28-35 (Pubitemid 30066492)
12. Grover M, Singh B, Bakshi M, et al. Quantitative structure-property relationships in pharmaceutical research-part 2. Pharm Sci Technol Today 2000;3(2):50-7 (Pubitemid 30101631)
13. Hansch C, Fujita T. p-tau-pi analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc 1964;86(8):1616-26
14. Contrera JF, MacLaughlin P, Hall LH, et al. QSAR modeling of carcinogenic risk using discriminant analysis and topological molecular descriptors. Curr Drug Discov Technol 2005;2(2):55-67 (Pubitemid 40943977)
15. van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2003;2(3):192-204 (Pubitemid 37361664)
16. Proudfoot JR. Drugs, leads, and druglikeness: an analysis of some recently launched drugs. Bioorg Med Chem Lett 2002;12(12):1647-50 (Pubitemid 34569263)
17. Roche O, Schneider P, Zuegge J, et al. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. J Med Chem 2002;45(1):137-42 (Pubitemid 34038548)
18. Galvez-Llompart M, Giner M, Recio C, et al. Application of molecular topology to the search of novel NSAIDs: experimental validation of activity. Lett Drug Des Discov 2010;7(6):438-45
19. de Julian-Ortiz JV, Galvez J, Munoz-Collado C, et al. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. J Med Chem 1999;42(17):3308-14 (Pubitemid 29409719)
20. Bruno-Blanch L, Galvez J, Garcia-Domenech R. Topological virtual screening: A way to find new anticonvulsant drugs from chemical diversity. Bioorg Med Chem Lett 2003;13(16):2749-54 (Pubitemid 36851563)
21. Rios-Santamarina I, Garcia-Domenech R, Galvez J. New bronchodilators selected by molecular topology. Bioorg Med Chem Lett 1998;8(5):477-82 (Pubitemid 28092378)
22. Galvez J, Garcia-Domenech R, de Julian-Ortiz J, et al. Topological approach to drug design. J Chem Inf Comput Sci 1995;35(2):272-84
23. Duart M, Garcia-Domenech R, Anton-Fos G, et al. Optimization of a mathematical topological pattern for the prediction of antihistaminic activity. J Comput Aided Mol Des 2001;15(6):561-72 (Pubitemid 32680853)
24. Galvez J, Garcia-Domenech R, Gomez-Lechon M, et al. Use of molecular topology in the selection of new cytostatic drugs. J Mol Struct Theochem 2000;504(1-3):241-8
25. de Gregorio Alapont C, Garcia-Domenech R, Galvez J, et al. Molecular topology: A useful tool for the search of new antibacterials. Bioorg Med Chem Lett 2000;10(17):2033-6 (Pubitemid 30663366)
26. Gonzales-Diaz H, Gia O, Uriarte E, et al. Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: discovery of anticancer compounds. J Mol Model 2003;9(6):395-407 (Pubitemid 38097528)
27. Oloff S, Mailman RB, Tropsha A. Application of validated QSAR models of D1 dopaminergic antagonists for database mining. J Med Chem 2005;48(23):7322-32 (Pubitemid 41743646)
28. Estrada E, Pena A. In silico studies for the rational discovery of anticonvulsant compounds. Bioorg Med Chem 2000;8(12):2755-70
29. Estrada E, Vilar S, Uriarte E, et al. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives. J Chem Inf Comput Sci 2002;42(5):1194-203 (Pubitemid 35360305)
30. Le-Thi-Thu H, Casanola-Martin GM, Marrero-Ponce Y, et al. Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database. Mol Divers 2010;5(2):507-20
31. Kumar V, Bansal H. QSAR studies on estimation of monoamine oxidase-A inhibitory activity using topological descriptors. Med Chem Res 2011;20(2):168-74
32. Prado-Prado F, Garcia-Mera X, Escobar M, et al. H. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins. Eur J Med Chem 2011;46(12):5838-51
33. Prado-Prado F, Garcia-Mera X, Abeijon P, et al. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica. Eur J Med Chem 2011;46(4):1074-94
34. Basak S, Mills D, Hawkins D, et al. Quantitative structure-activity relationship studies of antimalarial compounds from their calculated mathematical descriptors. SAR QSAR Environ Res 2010;21(1):103-25
35. Grassy G, Calas B, Yasri A, et al. Computer-assisted rational design of immunosuppressive compounds. Nat Biotechnol 1998;16(8):748-52 (Pubitemid 28363756)
36. Estrada E, Uriarte E. Recent advances on the role of topological indices in drug discovery research. Curr Med Chem 2001;8(13):1573-88 (Pubitemid 33076803)
37. Gonzalez-Diaz H, Vilar S, Santana L, et al. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr Top Med Chem 2007;7(10):1015-29 (Pubitemid 47040529)
38. Gozalbes R, Doucet J, Derouin F, et al. Application of topological descriptors in QSAR and drug design: History and new trends. Curr Drug Targets Infect Disord 2002;2(1):93-102 (Pubitemid 34649859)
39. Roy K. Topological descriptors in drug design and modeling studies. Mol Divers 2004;8(4):321-3 (Pubitemid 39491366)
40. Gonzalez-Diaz H. QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences. Curr Pharm Des 2010;16(24):2598-600
41. Gonzalez-Diaz H. Network topological indices, drug metabolism, and distribution. Curr Drug Metab 2010;11(4):283-4
42. Galvez J, Garcia-Domenech R, Bernal J, et al. Desarrollo de un nuevo metodo de diseno de farmacos por topologia molecular. Su aplicacion a analgesicos no narcoticos. An Real Acad Farm 1991;57:533-46
43. Pogliani L. From molecular connectivity indices to semiempirical connectivity terms: recent trends in graph theoretical descriptors. Chem Rev 2000;100(10):3827-58
44. Ivanciuc O, Ivanciuc T, Balaban AT. Quantitative structure-property relationship study of normal boiling points for halogen-/oxygen-/ sulfurcontaining organic compounds using the CODESSA program. Tetrahedron 1998;54(31):9129-42 (Pubitemid 28319975)
45. Hosoya H, Gotoh M, Murakami M, et al. Topological index and thermodynamic properties. 5. How can we explain the topological dependency of thermodynamic properties of alkanes with the topology of graphs? J Chem Inf Comput Sci 1999;39(2):192-6 (Pubitemid 129538903)
46. Garcia-Domenech R, Galvez J, de Julian-Ortiz JV, et al. Some new trends in chemical graph theory. Chem Rev 2008;108(3):1127-69 (Pubitemid 351577858)
47. Basak S, Mills D, Gute B, et al. Predicting pharmacological and toxicological activity of heterocyclic compounds using QSAR and molecular modeling. QSAR Mol Model Stud Heterocyclic Drugs I 2006;3:39-80
48. Balaban AT, Motoc I, Bonchev D, et al. Topological indices for structure-activity correlations. Top Curr Chem 1983;114:21-55
49. Marrero Ponce Y. Total and local (atom and atom type) molecular quadratic indices: Significance interpretation, comparison to other molecular descriptors, and QSPR/QSAR applications. Bioorg Med Chem 2004;12(24):6351-69 (Pubitemid 39535160)
50. Dudek AZ, Arodz T, Galvez J. Computational methods in developing quantitative structure-activity relationships (QSAR): a review. Comb Chem High Throughput Screen 2006;9(3):213-28
51. Wiener H. Structural determination of paraffin boiling points. J Am Chem Soc 1947;69(1):17-20
52. Randic M. Characterization of molecular branching. J Am Chem Soc 1975;97(23):6609-15
53. Kier LB, Murray WJ, Randic M, et al. Molecular connectivity V: connectivity series concept applied to density. J Pharm Sci 1976;65(8):1226-30
54. Kier LB. Shape indexes of orders one and three from molecular graphs. QSAR 1986;5(1):1-7 (Pubitemid 16134327)
55. Kier LB. An index of molecular flexibility from kappa shape attributes. QSAR 1989;8(3):221-4 (Pubitemid 19242018)
56. Galvez J, Garcia R, Salabert MT, et al. Charge indexes. New topological descriptors. J Chem Inf Comput Sci 1994;34(3):520-5
57. Balaban AT. Highly discriminating distance-based topological index. Chem Phys Lett 1982;89(5):399-404
58. Kier LB, Hall LH. An electrotopological-state index for atoms in molecules. Pharm Res 1990;7(8):801-7 (Pubitemid 20332531)
59. Estrada E. Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications to the prediction of physical properties of alkanes. J Chem Inf Comput Sci 1996;36(4):844-9 (Pubitemid 126581737)
60. EduSoft L. MolconnZ version 4.05. 2003
61. Todeschini R, Consonni V. DRAGON software (version 1.11-2001). Milano, Italy; 2003
62. Basak S, Harriss D, Magnuson V. POLLY 2.3. Copyright of the University of Minnesota; 1988
63. Katritzky A, Lobanov V, Karelson M. CODESSA software. University of Florida, SemiChem, Shawnee, KS; 1994. p. 211
64. Roy PP, Leonard JT, Roy K. Exploring the impact of size of training sets for the development of predictive QSAR models. Chem Intell Lab Syst 2008;90(1):31-42 (Pubitemid 350213175)
65. Besalu E. Fast computation of cross-validated properties in full linear leave-many-out procedures. J Math Chem 2001;29(3):191-204
66. Wold S, Eriksson L, Clementi S. Statistical validation of QSAR results. Chem Methods Mol Des 1995:309-38
67. Dixon WJ. BMDP statistical software manual: to accompany the 1990 software release. Univ of California Pr; San Francisco:1990
68. Lachenbruch PA, Mickey MR. Estimation of error rates in discriminant analysis. Technometrics 1968;10(1):1-11
69. Galvez J, Garcia-Domenech R, de Gregorio Alapont C, et al. Pharmacological distribution diagrams: a tool for de novo drug design. J Mol Graph 1996;14(5):272-6 (Pubitemid 27168648)
70. Todeschini R, Consonni V. Molecular descriptors for chemoinformatics. Wiley-Vch Verlag GmbH & Co. KGaA, Weinheim; 2008
71. Jasinski P, Welsh B, Galvez J, et al. A novel quinoline, MT477: Suppresses cell signaling through ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines. Invest New Drugs 2008;26(3):223-32 (Pubitemid 351579683)
72. Jasinski P, Zwolak P, Isaksson Vogel R, et al. MT103 inhibits tumor growth with minimal toxicity in murine model of lung carcinoma via induction of apoptosis. Invest New Drugs 2011;29(5):1-7
73. Mahmoudi N, Garcia-Domenech R, Galvez J, et al. New active drugs against liver stages of plasmodium predicted by molecular topology. Antimicrob Agents Chemother 2008;52(4):1215
74. Galvez J, Llompart J, Land D, et al. Mount Sinai School of Medicine of New York University, USA, Medisyn Technologies I, assignees. Compositions for treatment of Alzheimer's disease using Abeta-reducing and/or Abeta-anti-aggregation compounds. Patent Application Country: Application: WO; Patent Country: WO; Priority Application Country: US patent WO; 2010114636. 2010 1007; Patent Application Date: 20100405; Priority Application Date: 20090403
75. Duart MJ, Anton-Fos GM, Aleman PA, et al. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation. J Med Chem 2005;48(4):1260-4 (Pubitemid 40270470)
76. Arviza M. Prediccion e interpretacion de algunas propiedades fisicoquimicas y biologicas de un grupo de barbituricos y sulfonamidas por el metodo de conectividad molecular. PhD thesis, Universitat de Valencia, Spain; 1985
77. Dean PM, Zanders ED, Bailey DS. Industrial-scale, genomics-based drug design and discovery. Trends Biotechnol 2001;19(8): 288
78. Galvez J. On a topological interpretation of electronic and vibrational molecular energies. J Mol Struct (Theochem) 1998;429: 255-64 (Pubitemid 128388598)
79. Julian-Ortiz JV, de Gregorio C, Rios-Santamaria I, et al. Prediction of properties of chiral compounds by molecular topology. J Mol Graph Model 1998;16(1):14-18 (Pubitemid 29256003)
80. Castillo-Garit JA, Marrero-Ponce Y, Torrens F, et al. Bond-based 3D-Chiral linear indices: theory and QSAR applications to central chirality codification. J Comput Chem 2008;29(15): 2500-12
81. Ruiz-Blanco YB, Garcia Y, Sotomayor-Torres CM, et al. New set of 2D/3D thermodynamic indices for proteins. A formalism based on "molten globule" theory. Phys Procedia 2010;8:63-72
82. Galvez J. New strategies for the design of antivirals. Cap. The Viruses and Us. Valencian Foundation for Advanced Studies, DL; 2007. p. V-3751
83. Garcia-Domenech R, Catala AI, Garcia-Garcia A, et al. QSAR by molecular topology of 2,4-dihydroxythiobenzanilides -a virtual screening approach to optimize the antifungal activity. Indian J Chem B Org Chem Incl Med Chem 2002;41B(11):2376-84
84. Garcia-Domenech R, de Julian-Ortiz JV, Duart MJ, et al. Search of a topological pattern to evaluate toxicity of heterogeneous compounds. SAR QSAR Environ Res 2001;12(1-2):237-54
85. Gozalbes R, Brun-Pascaud M, Garcia-Domenech R, et al. Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: Prediction of activity by molecular topology and virtual computational techniques. Antimicrob Agents Chemother 2000;44(10):2771-6
86. Garcia-March FJ, Garcia-Domenech R, Galvez, J, et al. Pharmacological studies of 1-(p-chlorophenyl) propanol and 2-(1-hydroxy-3-butenyl) phenol: Two new Non-narcotic analgesics designed by molecular connectivity. J Pharm Pharmacol 1997;49(1):10-15 (Pubitemid 27051022)
87. Garcia-Domenech R, Domingo-Puig C, Esteve-Martinez M. Aplicacion de la topologia molecular en la busqueda de nuevos agentes activos frente a leishmania. An Real Acad Farm 2008;74:345-67
88. Garcia-Domenech R, Lopez-Pena W, Sanchez-Perdomo Y, et al. Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds. Int J Pharm 2008;363(1-2):78-84
89. Garcia-Domenech R, Alarcon-Elbal P, Bolas G, et al. Prediction of acute toxicity of organophosphorus pesticides using topological indices. SAR QSAR Environ Res 2007;7(8):745-55 (Pubitemid 350172711)
90. Garcia-Domenech R, Villanueva A, Galvez J. Application of molecular topology for the prediction of the toxicity of organic chemicals to chlorella vulgaris. Org Chem Indian J 2008;4(9-11):470-4
91. Garcia-Domenech R, Aguilera J, Moncef AE, et al. Application of molecular topology to the prediction of mosquito repellents of a group of terpenoid compounds. Mol Divers 2010;14(2):321-9
92. Gozalbes R, Brun-Pascaud M, Garcia-Domenech R, et al. Prediction of quinolone activity against mycobacterium avium by molecular topology and virtual computational screening. Antimicrob Agents Chemother 2000;44(10):2764-70
93. Pastor L, Garcia-Domenech R, Galvez J, et al. New antifungals selected by molecular topology. Bioorg Med Chem Lett 1998;8(18):2577-82 (Pubitemid 28546775)
94. Mahmoudi N, de Julian-Ortiz JV, Ciceron L, et al. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. J Antimicrob Chemother 2006;57(3):489-97 (Pubitemid 43240202)
95. Gozalbes R, Galvez J, Garcia-Domenech R, et al. Molecular search of new active drugs against toxoplasma gondii. SAR QSAR Environ Res 1999;10(1):47-60
96. Garcia-Domenech R, Garcia-March F, Soler R, et al. New analgesics designed by molecular topology. QSAR 1996;15(3):201-7 (Pubitemid 26225963)
97. Galvez J, Garcia-Domenech R, De Julian-Ortiz V, et al. Topological approach to analgesia. J Chem Inf Comput Sci 1994;34(5):1198-20398.
98. Galvez-Llompart M, Recio MC, Garcia-Domenech R. Topological virtual screening: A way to find new compounds active in ulcerative colitis by inhibiting NF-kappaB. Mol Divers 2011;15(4):917-26
99. Galvez J, Garcia-Domenech R. Molecular topology in QSAR and drug design studies. In: Castro EA, editor. QSPR-QSAR Studies on Desired Properties for Drug Design. Research Signpost; Kerala, India: 2010. p. 63-94
100. Anton-Fos G, Garcia-Domenech R, Perez-Gimenez F, et al. Pharmacological studies of the two new hypoglycaemic compounds 4-(3-methyl-5-oxo-2-pyrazolin-1- yl) benzoic acid and 1-(mesitylen-2-sulfonyl)-1H-1, 2, 4-triazole. Arzneimittelforschung 1994;44(7):821-6 (Pubitemid 24312405)
101. Galvez J, Gomez-Lechon M, Garcia-Domenech R, et al. New cytostatic agents obtained by molecular topology. Bioorg Med Chem Lett 1996;6(19):2301-6
102. Casaban-Ros E, Anton-Fos G, Galvez J, et al. Search for new antihistaminic compounds by molecular connectivity. QSAR 1999;18(1):35-42 (Pubitemid 29132531)
103. Estrada E, Pena A, Garcia-Domenech R. Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach. J Comput Aided Mol Des 1998;12(6):583-95] (Pubitemid 128512194)